Key points from article :
Scientists developed antibodies to block a protein and rejuvenate old brains in mice.
A new target for treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Humans and mice have gene to produce CD22 protein - responsible for age-related cognitive losses.
CD22 protein levels in microglia cells of brain increases with age.
Possibility to develop a drug to restore mental acuity of older population in the future.
2 months of continuous treatment improved performance of mice significantly.
Outperformed control mice of same age in two different learning and memory tests.
Study by the Stanford neuroscientists published in Nature.
